Family history and breast cancer hormone receptor status in a Spanish cohort

Citations of this article
Mendeley users who have this article in their library.


Background: Breast cancer is a heterogenous disease that impacts racial/ethnic groups differently. Differences in genetic composition, lifestyles, reproductive factors, or environmental exposures may contribute to the differential presentation of breast cancer among Hispanic women. Materials and Methods: A population-based study was conducted in the city of Santiago de Compostela, Spain. A total of 645 women diagnosed with operable invasive breast cancer between 1992 and 2005 participated in the study. Data on demographics, breast cancer risk factors, and clinico-pathological characteristics of the tumors were collected. Hormone receptor negative tumors were compared with hormone receptor postive tumors on their clinico-pathological characteristics as well as risk factor profiles. Results: Among the 645 breast cancer patients, 78% were estrogen receptor-positive (ER+) or progesterone receptor-positive (PR+), and 22% were ER-&PR-. Women with a family history of breast cancer were more likely to have ER-&PR- tumors than women without a family history (Odds ratio, 1.43; 95% confidence interval, 0.91-2.26). This association was limited to cancers diagnosed before age 50 (Odds ratio, 2.79; 95% confidence interval, 1.34-5.81). Conclusions: An increased proportion of ER-&PR- breast cancer was observed among younger Spanish women with a family history of the disease. © 2012 Jiang et al.




Jiang, X., Castelao, J. E., Chavez-Uribe, E., Rodriguez, B. F., Muñoz, C. C., Redondo, C. M., … Gago-Dominguez, M. (2012). Family history and breast cancer hormone receptor status in a Spanish cohort. PLoS ONE, 7(1).

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free